CORT: Corcept Therapeutics Incorporated

68.39 USD 0.95 (1.37%)

Sector: Atención Sanitaria Básica: US Dollar Divisa de beneficio: US Dollar

El tipo de cambio de CORT de hoy ha cambiado un -1.37%. En este caso, el precio mínimo en el mercado ha alcanzado 67.61, mientras que el máximo ha alcanzado 70.10.

Siga la dinámica de la pareja de divisas Corcept Therapeutics Incorporated. El gráfico histórico le mostrará cómo ha cambiado el precio de %AssetName% en el pasado. Alternando entre diferentes marcos temporales, podrá monitorear las tendencias y la dinámica del tipo de cambio por minutos, horas, días, semanas y meses. Use esta información para predecir los cambios en el mercado y tomar decisiones comerciales fundamentadas.

Gráfico a pantalla completa

CORT News

Seeking Alpha 13:50 ClearBridge Small Cap Strategy Q2 2025 Commentary
Zacks 11:10 Madrigal (MDGL) Moves 10.9% Higher: Will This Strength Last?
Seeking Alpha 21:13 XPH: Healthcare Dashboard For July (NYSEARCA:XPH)
Zacks 14:17 Corcept Seeks FDA Approval for Relacorilant in Ovarian Cancer
Investing 12:18 Corcept submits new drug application for ovarian cancer treatment
Investing 14:34 Piper Sandler reiterates Overweight rating on Corcept Therapeutics stock
Seeking Alpha 20:33 ClearBridge Global Value Improvers Strategy Q2 2025 Commentary
Investing 00:42 Corcept therapeutics officer Guyer sells $7350 in shares
Seeking Alpha 05:45 Beyond Cushing’s: The Undervalued Potential Of Corcept's Cortisol Modulators
Investing 13:17 Truist reiterates buy rating on Corcept stock, citing diabetes opportunity
Seeking Alpha 19:09 Calamos Timpani Small Cap Growth Fund Q1 2025 Commentary
Investing 20:41 Cortisol modulator improves glucose control in diabetes patients
Seeking Alpha 17:24 IHE: Healthcare Dashboard For June (NYSEARCA:IHE)
Investing 21:06 Corcept reports annual meeting outcomes
Investing 17:14 Corcept May 2025 slides: Revenue target of $900-950M amid pipeline advances
Seeking Alpha 21:37 Corcept: Remains A Strong Buy On Recent Weakness And Aggressive Sales Force Hiring
Investing 00:49 Corcept Therapeutics director Daniel Swisher sells $155k in stock
Seeking Alpha 08:51 American Century Small Cap Growth Fund Q1 2025 Commentary
Seeking Alpha 05:11 Tracking RenTech’s 13F Portfolio – Q1 2025 Update
Seeking Alpha 14:18 Harbor AlphaEdge Small Cap Earners ETF Q1 2025 Commentary (EBIT)
Benzinga 15:20 Corcept Therapeutics Therapy Fails Primary Goal But Extends Patient Survival In Amyotrophic Lateral Sclerosis Study - Corcept Therapeutics (NASDAQ:CORT)
Investing 10:12 Corcept Presents Results from Phase 2 Study of Dazucorilant in Patients with Amyotrophic Lateral Sclerosis (ALS) at ENCALS 2025 Annual Meeting
Investing 00:37 Corcept therapeutics officer Joseph Lyon sells shares worth $390,218
Seeking Alpha 12:00 abrdn U.S. Small Cap Equity Fund Q1 2025 Commentary

Rango diario

67.61 70.10

Rango anual

32.39 117.34

Cierres anteriores: 69.08
Open: 69.34

Bid: 68.39
Ask: 68.69

Low: 67.61
High: 70.10

Volumen: 1.832 K

Cambio diario: -1.37%
Cambio mensual: -6.70%

Cambio a 6 meses: 4.67%
Cambio anual: 76.86%

24 julio, jueves